BioMarin Pharmaceutical Inc. Stock Price (Quote)

$88.49 ( -0.276% ) Friday, 26th May 2023

Range	Low Price	High Price	Comment
30 days	$87.81	$97.42	Friday, 26th May 2023 BMRN stock ended at $88.49. This is 0.276% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 1.50% from a day low at $88.48 to a day high of $89.81.
90 days	$87.34	$103.58
52 weeks	$70.73	$117.77

Historical BioMarin Pharmaceutical Inc. prices

Date	Open	High	Low	Close	Volume
2016-04-05	$83.99	$84.70	$82.48	$83.02	808 606
2016-04-04	$85.67	$87.17	$84.34	$84.47	1 040 677
2016-04-01	$81.46	$86.72	$81.03	$84.66	1 592 730
2016-03-31	$79.09	$84.12	$78.35	$82.48	2 162 392
2016-03-30	$79.37	$81.50	$77.10	$78.29	779 470
2016-03-29	$79.01	$79.93	$76.42	$78.76	1 455 000
2016-03-28	$81.35	$81.45	$78.87	$79.00	713 300
2016-03-24	$80.82	$83.01	$78.42	$80.87	1 545 400
2016-03-23	$83.18	$85.32	$80.34	$80.61	2 186 800
2016-03-22	$77.46	$83.66	$77.46	$83.43	2 615 100
2016-03-21	$76.13	$79.81	$75.90	$78.19	2 746 400
2016-03-18	$77.81	$81.47	$77.08	$80.94	2 456 900
2016-03-17	$80.40	$80.40	$74.67	$77.32	2 961 100
2016-03-16	$82.81	$84.00	$78.61	$80.34	1 462 800
2016-03-15	$85.44	$85.55	$82.40	$83.43	1 147 000
2016-03-14	$87.52	$88.76	$85.47	$85.98	1 452 100
2016-03-11	$84.60	$88.54	$83.59	$88.27	1 301 500
2016-03-10	$86.54	$86.54	$81.32	$83.60	1 288 300
2016-03-09	$85.86	$86.21	$82.51	$85.22	1 489 500
2016-03-08	$89.36	$90.46	$85.29	$85.54	1 330 800
2016-03-07	$87.70	$89.84	$86.18	$88.22	1 761 600
2016-03-04	$89.73	$89.83	$86.47	$86.67	1 744 500
2016-03-03	$88.91	$90.99	$88.28	$89.57	2 802 800
2016-03-02	$87.44	$90.34	$84.00	$87.44	2 080 500
2016-03-01	$82.50	$88.04	$81.03	$87.57	2 372 900
2016-02-29	$80.75	$84.90	$80.62	$81.87	2 410 200
2016-02-26	$76.64	$82.11	$74.80	$80.14	2 299 000
2016-02-25	$76.92	$78.91	$74.64	$76.41	1 840 500
2016-02-24	$74.31	$76.52	$72.96	$76.34	1 465 100
2016-02-23	$78.11	$80.25	$75.48	$75.61	1 764 300
2016-02-22	$79.05	$81.90	$76.75	$78.49	1 620 500
2016-02-19	$74.55	$77.91	$73.28	$77.70	1 983 100
2016-02-18	$78.36	$78.80	$74.45	$74.87	1 830 300
2016-02-17	$75.16	$79.63	$73.61	$77.81	2 542 100
2016-02-16	$72.11	$74.40	$71.49	$74.26	2 437 800
2016-02-12	$68.00	$71.25	$67.07	$70.08	2 152 500
2016-02-11	$65.43	$68.89	$65.03	$67.26	1 641 700
2016-02-10	$65.96	$70.76	$65.57	$67.02	1 853 400
2016-02-09	$63.59	$67.40	$62.12	$65.11	2 450 700
2016-02-08	$68.17	$68.17	$63.71	$64.74	1 794 000
2016-02-05	$70.75	$71.58	$66.20	$68.41	2 222 700
2016-02-04	$71.50	$73.78	$69.57	$71.15	2 227 900
2016-02-03	$72.37	$74.69	$67.53	$71.91	2 201 100
2016-02-02	$74.44	$76.00	$71.78	$72.04	1 552 900
2016-02-01	$73.81	$76.70	$73.27	$75.65	2 329 500
2016-01-29	$73.84	$75.50	$70.25	$74.02	3 262 400
2016-01-28	$80.72	$81.02	$72.53	$73.38	2 859 600
2016-01-27	$86.18	$87.93	$79.15	$80.14	1 704 900
2016-01-26	$84.62	$87.25	$82.05	$86.04	1 244 900
2016-01-25	$83.86	$87.52	$83.86	$85.01	1 492 200

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by